ES2078253T3 - Sintetasa de la sustancia ron biologicamente activa y su uso para producir sustancia ron biologicamente activa. - Google Patents

Sintetasa de la sustancia ron biologicamente activa y su uso para producir sustancia ron biologicamente activa.

Info

Publication number
ES2078253T3
ES2078253T3 ES90102132T ES90102132T ES2078253T3 ES 2078253 T3 ES2078253 T3 ES 2078253T3 ES 90102132 T ES90102132 T ES 90102132T ES 90102132 T ES90102132 T ES 90102132T ES 2078253 T3 ES2078253 T3 ES 2078253T3
Authority
ES
Spain
Prior art keywords
biologically active
rum
substance
syntheses
produce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90102132T
Other languages
English (en)
Inventor
Yasuo Yoneta
Hisao Kado
Suguru Takeo
Yutaka Mitani
Nobuhiro Watanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sapporo Breweries Ltd
Original Assignee
Sapporo Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sapporo Holdings Ltd filed Critical Sapporo Holdings Ltd
Application granted granted Critical
Publication of ES2078253T3 publication Critical patent/ES2078253T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C12P19/08—Dextran
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2451—Glucanases acting on alpha-1,6-glucosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

UNA SUBSTANCIA RON POLISACARIDA BIOLOGICAMENTE ACTIVA, LA CUAL ES EXCELENTE EN ACTIVIDADES BIOLOGICAS TALES COMO ACTIVIDADES ANTI-TUMORALES, ACTIVIDADES INMUNOMODULADORAS Y ACTIVIDAD DE DEFENSA DEL PORTADOR CONTRA ENFERMEDADES INFECCIOSAS, Y PROCESO PARA PRODUCIR DICHA SUBSTANCIA RON TRATANDO SACAROSA CON DICHA SUBSTANCIA RON SINTETICA.FIG 1.
ES90102132T 1989-02-08 1990-02-03 Sintetasa de la sustancia ron biologicamente activa y su uso para producir sustancia ron biologicamente activa. Expired - Lifetime ES2078253T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2938289 1989-02-08

Publications (1)

Publication Number Publication Date
ES2078253T3 true ES2078253T3 (es) 1995-12-16

Family

ID=12274589

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90102132T Expired - Lifetime ES2078253T3 (es) 1989-02-08 1990-02-03 Sintetasa de la sustancia ron biologicamente activa y su uso para producir sustancia ron biologicamente activa.

Country Status (7)

Country Link
US (1) US5565342A (es)
EP (1) EP0382121B1 (es)
JP (1) JPH0740953B2 (es)
KR (1) KR900013073A (es)
CA (1) CA2009193A1 (es)
DE (1) DE69021599T2 (es)
ES (1) ES2078253T3 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1530642T3 (da) * 2002-08-06 2010-03-08 Danisco Brug af lactobacillus til fremstilling af exopolysaccharider i fødevarer og farmaceutiske sammensætninger
US6958039B2 (en) 2003-05-02 2005-10-25 Oculir, Inc. Method and instruments for non-invasive analyte measurement
US6975892B2 (en) 2003-10-21 2005-12-13 Oculir, Inc. Methods for non-invasive analyte measurement from the conjunctiva
US6968222B2 (en) 2003-05-02 2005-11-22 Oculir, Inc. Methods and device for non-invasive analyte measurement
US20060258919A1 (en) * 2004-04-14 2006-11-16 Oculir, Inc. Non-Invasive Analyte Measurement Device for Measuring Tears and Other Ocular Elements Using Electromagnetic Radiation and Method of Using the Same
US20080009688A1 (en) * 2004-04-14 2008-01-10 Oculir, Inc. Methods for non-invasive analyte measurement
CN107198015A (zh) * 2017-04-24 2017-09-26 杭州研青生物科技有限公司 双菌半干法发酵脱脂米糠获得活性物的方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2823128A (en) * 1953-05-29 1958-02-11 Ohio Commw Eng Co Stabilized and bodied ice cream
JPS6153220A (ja) * 1984-08-22 1986-03-17 Sapporo Breweries Ltd 新規多糖体ｒｏｎ物質，その製造法およびそれを有効成分とする抗腫瘍剤，免疫調節剤並びに感染症予防治療剤
SE439647B (sv) * 1982-02-18 1985-06-24 Sorigona Ab Kontinuerligt forfarande for framstellning av dextran
DE3224547A1 (de) * 1982-07-01 1984-01-05 Henkel KGaA, 4000 Düsseldorf Verbessertes verfahren zur herstellung von exozellulaeren biopolymeren

Also Published As

Publication number Publication date
CA2009193A1 (en) 1990-08-08
EP0382121A1 (en) 1990-08-16
JPH0740953B2 (ja) 1995-05-10
EP0382121B1 (en) 1995-08-16
US5565342A (en) 1996-10-15
DE69021599T2 (de) 1996-02-15
JPH03224494A (ja) 1991-10-03
DE69021599D1 (de) 1995-09-21
KR900013073A (ko) 1990-09-03

Similar Documents

Publication Publication Date Title
HU902330D0 (en) Clycoprotein of human origine physiologically active factor consisting of it and pharmaceutical preparative containing it as active substance
DE3883374D1 (de) Acylatiertes uridin und cytidin und deren verwendungen.
AU4986797A (en) Monocyclic l-nucleosides, analogs and uses thereof
AR023762A2 (es) Metodo para producir un polipeptido modificado cry3bb con actividad o especificidad insecticida mejorada, metodo para aumentar la movilidad de helicesformadoras de canales de un polipeptido cry3bb, metodo para aumentar la flexibilidad de una region bucle en un dominio de formacion de canales del pol
ES2010226A6 (es) Un procedimiento para producir una preparacion farmaceutica estable que contiene un factor estimulante de colonias de granulocitos
RU95108590A (ru) Производные имидазола
ATE133181T1 (de) Dehydrodidemnin b
ES2151607T3 (es) Factor 12 de crecimiento y de diferenciacion.
FI885807L (fi) Puhdistetun, biologisesti aktiivisen, bakteerien avulla tuotetun rekombinanttisen ihmis- CSF-1:n tuottaminen
ES8403157A1 (es) Un metodo de preparar sustancias biologicamente activas que tienen actividad anti-tumoral.
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
IT7922818A0 (it) Procedimento per mantenere attiva la cultura di fermenti.
IT1271088B (it) Uso di fattore di crescita degli epatociti per indurre la proliferazione e differenziazione di cellule emopoietiche
ES2124235T3 (es) Uso de tri(n-butil) fosfato a bajo ph en soluciones de proteinas biologicamente activas para mejorar la actividad viricida.
ES2075075T3 (es) Metodo para la preparacion de un substancia polisacarida ron.
ES2017677B3 (es) 4-benciloxi-3-pirrolin-2-ona-1-il-acetamida, obtencion y aplicaciones.
AU513963B2 (en) Biologically active substance having insulin secretion promoting activity
EE03170B1 (et) Perifeerse vere mononukleaarsete rakkude tsütotoksilise aktiivsuse stimuleerimine IL-10 abil
ATE108326T1 (de) Wässerige desmopressin-cmc enthaltende arzneizubereitung.
BG46743A3 (en) Method for preparing of alkanoyl anilides
FR2657258B1 (es)
IT7924358A0 (it) Antibiotici, procedimento per laloro preparazione, e coltura biologicamente pura per impiego in tale procedimento.
ES2057528T3 (es) Pdgf-a, pdgf-aa, pdgf-ab, procedimientos de preparacion y medicamentos que los contienen.
ES2150034T3 (es) Empleo de las 2-aminotetralinas substituidas en 6,7 para la preparacion de composiciones farmaceuticas de utilidad para el tratamiento del choque septico, y composiciones farmaceuticas antipireticas y antiinflamatorias.
RU99106460A (ru) Порошковая смесь

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 382121

Country of ref document: ES